In the News

OmniActive Gets $35 Million to Accelerate Growth in Nutraceuticals

By January 2, 2017 November 20th, 2019 No Comments

The Everstone Group has invested $35 million (USD) in Mumbai-based OmniActive Health Technologies Ltd. to further accelerate its growth in the fast-expanding nutraceuticals space. The deal is Everstone’s third in the healthcare and wellness sector in less than a year.

OmniActive is a leading supplier of naturally sourced ingredients for eye health, weight management and heart health to global nutraceutical companies that provide food supplements and nutritional fortification. OmniActive has a research-driven approach, state of the art manufacturing facilities, well-equipped R&D centers across India and Canada, and sales and marketing presence across the U.S., Europe and Asia. In the last 18 months, innovation-driven OmniActive completed 12 human clinical trials in healthy populations across its portfolio of branded ingredients. The company has a very strong presence in the U.S. and is working to achieve similar success in Europe and Asia.